209P Trastuzumab plus lapatinib or chemotherapy in patients with HER2-positive advanced breast cancer refractory to anti-HER2 therapies: A randomized, multicenter, phase II trial (GIM12-TYPHER)

Authors :: C. De Angelis
M. Pagliuca
T. Gamucci
M. Mansutti
Z. Ballatore
M. De Laurentiis
R. Bordonaro
A. Pazzola
V. Leonardi
D. Bruzzese
A.M. Mosconi
C. Molica
S. Cinieri
A. Fabi
L. Del Mastro
F. Puglisi
S. de Placido
M. Giuliano
G. Arpino
Source :: ESMO Open. 8:101398
Publication Year :: 2023
Publisher :: Elsevier BV, 2023.

Full Text Access

Tools